Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.,Nature Medicine

当前位置： X-MOL 学术 › Nat. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.
Nature Medicine ( IF 58.7 ) Pub Date : 2020-06-18 , DOI: 10.1038/s41591-020-0973-6
You Lu ₁ , Jianxin Xue ₁ , Tao Deng ₂ , Xiaojuan Zhou ₁ , Kun Yu ₂ , Lei Deng ₃ , Meijuan Huang ₁ , Xin Yi ₄ , Maozhi Liang ₅ , Yu Wang ₆ , Haige Shen ₆ , Ruizhan Tong ₁ , Wenbo Wang ₇ , Li Li ₁ , Jin Song ₄ , Jing Li ₄ , Xiaoxing Su ₈ , Zhenyu Ding ₁ , Youling Gong ₁ , Jiang Zhu ₁ , Yongsheng Wang _{1,

5} , Bingwen Zou ₁ , Yan Zhang ₁ , Yanying Li ₁ , Lin Zhou ₁ , Yongmei Liu ₁ , Min Yu ₁ , Yuqi Wang ₄ , Xuanwei Zhang ₁ , Limei Yin ₁ , Xuefeng Xia ₄ , Yong Zeng ₂ , Qiao Zhou ₉ , Binwu Ying ₁₀ , Chong Chen ₁₁ , Yuquan Wei ₁₁ , Weimin Li ₁₂ , Tony Mok ₁₃

Affiliation

Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Chengdu MedGenCell, Co., Ltd, Chengdu, China.
Jacobi Medical Center, NYC Health Hospitals, Albert Einstein College of Medicine, New York, NY, USA.
Geneplus-Beijing Institute, Beijing, China.
Center of GCP, West China Hospital, Sichuan University, Chengdu, China.
ZenRhyme Consulting Service, Ltd, Shanghai, China.
National Research Center for Translational Medicine, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Berry Oncology Co. Ltd, Fujian, China.
Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
State Key Laboratory of Biotherapy and Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Department of Respiratory and Critical Care Medicine and Frontier Science Center of Disease Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, China.